Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials

Reynold A. Panettieri, Ulf Sjöbring, AnnaMaria Péterffy, Peter Wessman, Karin Bowen, Edward Piper, Gene Colice, Christopher E. Brightling

The Lancet Respiratory Medicine · 2018 · 227 citations · 36 references

DOIFull text

Open access

Concepts

References

36